You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 12, March 23/30, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (41)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Substance Abuse/ Alcoholism
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Risk Factors for Relapse in Health Care Professionals With Substance Use Disorders

Karen B. Domino, MD, MPH; Thomas F. Hornbein, MD; Nayak L. Polissar, PhD; Ginger Renner; Jilda Johnson; Scott Alberti; Lynn Hankes, MD

JAMA. 2005;293:1453-1460.

Context  Substance use disorders among physicians are important and persistent problems. Considerable debate exists over whether use of major opioids, especially among anesthesiologists, is associated with a higher relapse rate compared with alcohol and nonopioids. Moreover, the risk factors for relapse with current treatment and monitoring strategies are unknown.

Objective  To test the hypothesis that chemically dependent health care professionals using a major opioid (eg, fentanyl, sufentanil, morphine, meperidine) as drug of choice are at higher risk of relapse.

Design, Setting, and Participants  Retrospective cohort study of 292 health care professionals enrolled in the Washington Physicians Health Program, an independent posttreatment monitoring program, followed up between January 1, 1991, and December 31, 2001.

Main Outcome Measure  Factors associated with relapse, defined as the resumption of substance use after initial diagnosis and completion of primary treatment for chemical dependency.

Results  Twenty-five percent (74 of 292 individuals) had at least 1 relapse. A family history of a substance use disorder increased the risk of relapse (hazard ratio [HR], 2.29; 95% confidence interval [CI], 1.44-3.64). The use of a major opioid increased the risk of relapse significantly in the presence of a coexisting psychiatric disorder (HR, 5.79; 95% CI, 2.89-11.42) but not in the absence of a coexisting psychiatric disorder (HR, 0.85; 95% CI, 0.33-2.17). The presence of all 3 factors—major opioid use, dual diagnosis, and family history—markedly increased the risk of relapse (HR, 13.25; 95% CI, 5.22-33.59). The risk of subsequent relapses increased after the first relapse (HR, 1.69; 95% CI, 1.13-2.53).

Conclusions  The risk of relapse with substance use was increased in health care professionals who used a major opioid or had a coexisting psychiatric illness or a family history of a substance use disorder. The presence of more than 1 of these risk factors and previous relapse further increased the likelihood of relapse. These observations should be considered in monitoring the recovery of health care professionals.


Author Affiliations: Departments of Anesthesiology (Drs Domino and Hornbein) and Psychiatry (Dr Hankes), University of Washington, Seattle; Mountain-Whisper-Light Statistical Consulting, Seattle (Dr Polissar); and Washington Physicians Health Program, Seattle (Dr Hankes and Mss Renner and Johnson and Mr Alberti).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Physician Substance Abuse and Recovery: What Does It Mean for Physicians—and Everyone Else?
David R. Gastfriend
JAMA. 2005;293(12):1513-1515.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Confrontational Approach Has No Role in Addressing Physician Addiction
Skipper
Mayo Clin Proc. 2009;84:1042-1042.
FULL TEXT  

Confrontational Approach Has No Role in Addressing Physician Addiction-Reply-I
Berge
Mayo Clin Proc. 2009;84:1042-1043.
FULL TEXT  

Anesthesiologists with Substance Use Disorders: A 5-Year Outcome Study from 16 State Physician Health Programs
Skipper et al.
Anesth. Analg. 2009;109:891-896.
ABSTRACT | FULL TEXT  

Anesthesiologists Recovering From Chemical Dependency: Can They Safely Return to the Operating Room?
Oreskovich and Caldeiro
Mayo Clin Proc. 2009;84:576-580.
FULL TEXT  

Chemical Dependency and the Physician
Berge et al.
Mayo Clin Proc. 2009;84:625-631.
ABSTRACT | FULL TEXT  

Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States
McLellan et al.
BMJ 2008;337:a2038-a2038.
ABSTRACT | FULL TEXT  

Addicted anesthesiology residents: recommendations after treatment.
Matsumura and Berry
Anesth. Analg. 2006;103:513-515.
FULL TEXT  

Forensic psychiatric assessments of behaviorally disruptive physicians.
Meyer and Price
J Am Acad Psychiatry Law 2006;34:72-81.
ABSTRACT | FULL TEXT  

Substance Abuse in Healthcare Professionals: Why Do They Relapse?
JWatch Emergency Med. 2005;2005:10-10.
FULL TEXT  

Clinicians with Histories of Substance Abuse: What Leads to Relapse?
JWatch Psychiatry 2005;2005:6-6.
FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2005;330:749-749.
FULL TEXT  

Physician Substance Abuse and Recovery: What Does It Mean for Physicians--and Everyone Else?
Gastfriend
JAMA 2005;293:1513-1515.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.